{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:31:39Z","timestamp":1771493499866,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Federal Ministry for Education and Science (BMBF) \u2013 KVSF","award":["02NUK006A+B"],"award-info":[{"award-number":["02NUK006A+B"]}]}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.radonc.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T19:04:22Z","timestamp":1389899062000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential"],"prefix":"10.1016","volume":"110","author":[{"given":"Lydia","family":"Koi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Br\u00fcchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5779-9675","authenticated-orcid":false,"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2013.12.001_b0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2013.12.001_b0010","series-title":"Stem cells","first-page":"363","article-title":"Tumour stem cells","author":"Kummermehr","year":"1997"},{"key":"10.1016\/j.radonc.2013.12.001_b0015","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1158\/1078-0432.CCR-10-2639","article-title":"Cancer stem cells: targets and potential biomarkers for radiotherapy","volume":"17","author":"Krause","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2013.12.001_b0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2010.02.003","article-title":"Cancer stem cells at the crossroads of current cancer therapy failures \u2013 radiation oncology perspective","volume":"20","author":"Koch","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.radonc.2013.12.001_b0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09553000902836404","article-title":"Cancer stem cells and radiotherapy","volume":"85","author":"Baumann","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2013.12.001_b0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2006.07.017","article-title":"Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy","volume":"80","author":"Krause","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0035","first-page":"2703","article-title":"Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy","volume":"3","author":"Mendelsohn","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2013.12.001_b0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2013.12.001_b0045","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2013.12.001_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.radonc.2013.12.001_b0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.radonc.2007.04.006","article-title":"EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms","volume":"83","author":"Baumann","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2006.09.044","article-title":"Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation","volume":"67","author":"Milas","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.radonc.2011.05.035","article-title":"Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression","volume":"99","author":"Gurtner","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2013.12.001_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0360-3016(01)01671-6","article-title":"C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability","volume":"51","author":"Nasu","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2004.10.011","article-title":"Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC","volume":"74","author":"Krause","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ijrobp.2007.10.040","article-title":"Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment","volume":"71","author":"Caudell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.oraloncology.2003.11.009","article-title":"Radioimmunodetection and radioimmunotherapy of head and neck cancer","volume":"40","author":"Borjesson","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0095","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2009.12.030","article-title":"External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma","volume":"79","author":"Burdick","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.2000.tb06714.x","article-title":"Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy","volume":"910","author":"Buchegger","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.radonc.2013.12.001_b0105","first-page":"83","article-title":"Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice","volume":"55","author":"Buchegger","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2013.12.001_b0110","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/cncr.10302","article-title":"The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody","volume":"94","author":"Johansson","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2013.12.001_b0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00259-003-1177-2","article-title":"Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours","volume":"30","author":"Eriksson","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2013.12.001_b0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00066-012-0121-4","article-title":"Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro","volume":"188","author":"Saki","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2013.12.001_b0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2006.08.010","article-title":"Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies","volume":"81","author":"Yaromina","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.radonc.2007.04.020","article-title":"Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation","volume":"83","author":"Yaromina","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0135","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.02.015","article-title":"Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts","volume":"80","author":"Yaromina","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2010.04.020","article-title":"Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation","volume":"96","author":"Yaromina","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00280-005-1022-3","article-title":"Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft","volume":"56","author":"Luo","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.radonc.2013.12.001_b0150","first-page":"1530","article-title":"Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225","volume":"42","author":"Wen","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2013.12.001_b0155","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1158\/1535-7163.MCT-10-0444","article-title":"Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab","volume":"9","author":"Liu","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.radonc.2013.12.001_b0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cyto.a.22110","article-title":"Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation","volume":"81","author":"Ingargiola","year":"2012","journal-title":"Cytometry A"},{"key":"10.1016\/j.radonc.2013.12.001_b0165","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.12.001_b0170","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2967\/jnumed.111.101857","article-title":"Inactivation of HNSCC cells by 90Y-labeled cetuximab strictly depends on the number of induced DNA double-strand breaks","volume":"54","author":"Saker","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2013.12.001_b0175","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2011.02.043","article-title":"Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification","volume":"80","author":"Kasten-Pisula","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.12.001_b0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.108.054312","article-title":"Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET","volume":"50","author":"Aerts","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2013.12.001_b0185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2967\/jnumed.109.061820","article-title":"PET of EGFR antibody distribution in head and neck squamous cell carcinoma models","volume":"50","author":"Niu","year":"2009","journal-title":"J Nucl Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013006427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013006427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T04:55:20Z","timestamp":1538888120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814013006427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0167814013006427"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2013.12.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}